114 related articles for article (PubMed ID: 2844199)
1. Simultaneous flow cytometric detection of nuclear DNA and tumor-associated antigens in lung cancers.
Inoue S; Ito M; Mizuno S; Isobe H; Miyamoto H; Kawakami Y; Ohnuma T
Anal Quant Cytol Histol; 1988 Aug; 10(4):243-50. PubMed ID: 2844199
[TBL] [Abstract][Full Text] [Related]
2. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
[No Abstract] [Full Text] [Related]
6. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
[TBL] [Abstract][Full Text] [Related]
7. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
8. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?].
Jany B; Fischbach W; Chowanetz W
Med Klin (Munich); 1988 Feb; 83(4):121-4, 158. PubMed ID: 3367874
[No Abstract] [Full Text] [Related]
9. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
[TBL] [Abstract][Full Text] [Related]
10. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
11. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
12. In vitro confirmation of newly established lung cancer cell lines using flow cytometry and multicellular tumor spheroids.
Inoue S; Takaoka K; Endo T; Mizuno S; Ogawa Y; Yoshida M; Ohnuma T
Lung Cancer; 1997 May; 17(1):85-101. PubMed ID: 9194029
[TBL] [Abstract][Full Text] [Related]
13. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer.
Załeska J; Pirozynski M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():179-89. PubMed ID: 9337536
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
[TBL] [Abstract][Full Text] [Related]
15. [Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer].
Załteska J; Pirozyński M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1996; 64(1-2):11-8. PubMed ID: 8630459
[TBL] [Abstract][Full Text] [Related]
16. [Tumor marker in lung cancer].
Shijubo N; Abe S
Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
[No Abstract] [Full Text] [Related]
17. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
Leonardo E; Dogliotti C; Oliaro A
Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
[TBL] [Abstract][Full Text] [Related]
18. TA 4-SCC versus CEA sensitivity for lung cancer.
Pecchio F; Rapellino M; Ricci E; Casadio C; Moscato D; Adamo R; Miserendino L; Sansalvadore F
Tumori; 1988 Aug; 74(4):393-5. PubMed ID: 2847383
[TBL] [Abstract][Full Text] [Related]
19. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
20. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]